|
Co-Prenessa 2 mg /0,625 mg tbl 100x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 100x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 14x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 14x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 20x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 20x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 28x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 28x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 30x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 30x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 50x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 50x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 56x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 56x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 60x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 60x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 90x2 mg /0,625 mg (OPA/Al/PVC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 2 mg /0,625 mg tbl 90x2 mg /0,625 mg (PVC/PE/PVDC/Al)
2 mg /0,625 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 100x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 100x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 14x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 14x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 20x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 20x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|